p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin.
about
ApoptomiRs of Breast Cancer: Basics to ClinicsProgesterone induces cellular differentiation in MDA-MB-231 breast cancer cells transfected with progesterone receptor complementary DNA.Precursors and preinvasive lesions of the breast: the role of molecular prognostic markers in the diagnostic and therapeutic dilemma.Prognostic value of molecular markers and cytogenetic alterations that characterize breast cancer precursor lesions (Review)High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses.The search for optimal cutoff points for apoptosis and proliferation rate in prognostification of early stage breast cancer patients treated with anthracyclines in adjuvant settings.Distribution of molecular breast cancer subtypes in middle eastern-saudi arabian women: a pilot study.Correlation between ER, PR, HER-2, Bcl-2, p53, proliferative and apoptotic indexes with HER-2 gene amplification and TOP2A gene amplification and deletion in four molecular subtypes of breast cancer.Relationship between the epithelial expression of hMLH1, MDM2, and p63 and lower lip carcinogenesis.Alterations of p53, BCL-2, and hMSH2 protein expression in the normal brain tissues, gliosis, and gliomas.Evaluation of the prognostic and predictive value of HER-1/EGFR in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy.Some DCIS is different molecularly from DCIS with co-existing IDC.Antimicrobial and antiproliferative prospective of kosinostatin - a secondary metabolite isolated from Streptomyces sp.Correlation between cell cycle proteins and hMSH2 in actinic cheilitis and lip cancer.Immunoexpression of human epidermal growth factor receptor-2 in apocrine carcinoma arising in naevus sebaceous, case report.
P2860
Q28072414-2A00F869-9098-47D9-8D32-77E20FA7D55FQ35791463-163C6573-4678-4BBC-89CB-0BFC5F1202FCQ35846896-7A8511D8-6461-4F96-9856-A43C20B18C10Q37269644-A074805E-3C30-4494-8BE0-0248E34F01DBQ38443265-F30B8026-13C6-41F4-B68D-874571919F06Q41034390-DBBFC3B8-500B-4664-A524-BBE27A26148DQ42459356-02C0F03F-3B26-4936-B7B7-ED8D3D6A0DA2Q44053869-5AD79D83-FC51-4AAF-93E3-6A633037709EQ44992018-BD130A80-1F05-4972-8F55-A0065FF9B321Q46749960-0C8F59B4-3BB2-4B71-BCA1-943CCA075200Q46813500-5A3C29DA-56D4-4BC3-9B63-85CECC8A78D3Q46814465-31631E92-A24F-4CF1-9E87-DDDE9DB0E52EQ49168230-EE4B96C1-1E6A-4E5C-A4AC-6C35A2A6888AQ52886161-53B88A64-7B49-4883-B49C-77FFFA47F465Q54724922-004B27E2-50DB-4E56-949F-F9E42D49A60F
P2860
p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin.
@ast
p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin.
@en
type
label
p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin.
@ast
p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin.
@en
prefLabel
p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin.
@ast
p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin.
@en
P2093
P2860
P50
P356
P1476
p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin
@en
P2093
P2860
P304
P356
10.1136/JCP.55.6.461
P407
P577
2002-06-01T00:00:00Z